Tag: Healthcare industry
STAT Wins Third Polk Award for Health Care Colossus Series
A team of four dynamic STAT reporters recently clinched the highly coveted George W. Polk Award, a prestigious accolade in the realm of American journalism. Their groundbreaking series shed light on the tactics employed...
Threat of Brain Drain Undermining U.S. Biomedicine Dominance
The U.S. Biomedicine Dominance in Peril: Threat of Brain Drain LoomsA sense of unease and uncertainty grips the scientific community as they grapple with the repercussions of the tumultuous policies set forth by the...
MAHA and RFK Jr.: Health Care Role Insights
In the realm of health care and medicine, the landscape is constantly evolving with the integration of technology and the influence of key figures. One such influential figure is Robert F. Kennedy Jr., whose...
Indiana Governor Appoints Business Leader to Transform Health Care
In a captivating tale of a seasoned leader's crusade against the convoluted world of health care, Gloria Sachdev emerges as a beacon of change in Indiana. Armed with a background in pharmacy and years...
Impact of Trump’s Tariffs on Healthcare Costs: Devices to Drugs
President Trump's recent decision to impose import taxes on goods from Canada, China, and Mexico has sparked concerns about potential increases in healthcare costs for American consumers. With tariffs of 25% on imports from...
Trump’s Funding Pause Creates Chaos for States and Health Industry
States and the nation’s health industry found themselves plunged into turmoil as the Trump administration issued a directive on Monday to freeze nearly all federal grants by 5 p.m. ET Tuesday. This comprehensive order...
The Shkreli Awards: Dysfunction and Profiteering in Health Care
The Shkreli Awards: A Deep Dive into Dysfunction and Profiteering in Health CareThe Eighth Annual Shkreli Awards, hosted by the Lown Institute, recently highlighted the most egregious examples of profiteering and dysfunction in the...
Pfizer Settles $60M Kickback Claims with Biohaven
Pfizer Settles $60M Kickback Claims with BiohavenPfizer, a leading pharmaceutical company, recently agreed to a significant settlement of nearly $60 million to resolve allegations of kickbacks involving its subsidiary, Biohaven Pharmaceuticals. The U.S. Department...
